Brevan Howard Capital Management’s Octave Specialty Group OSG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-18,197
Closed -$84.6K – 2063
2026
Q1
$84.6K Sell
18,197
-2,836
-13% -$16.2K ﹤0.01% 2051
2025
Q4
$164K Sell
21,033
-14,452
-41% -$124K ﹤0.01% 1624
2025
Q3
$296K Sell
35,485
-15,218
-30% -$129K ﹤0.01% 1573
2025
Q2
$360K Sell
50,703
-23,628
-32% -$176K ﹤0.01% 1487
2025
Q1
$650K Buy
+74,331
New +$783K 0.01% 647

Other funds holding OSG

Brevan Howard Capital Management's OSG Position: Q2 2026 in Review

Brevan Howard Capital Management sold out of Octave Specialty Group (OSG) in Q2 2026, closing a stake of 18,197 shares — an estimated $84.6K sold.

Brevan Howard Capital Management first reported a position in OSG in Q1 2025 and held it in 5 quarters. The position peaked at $650K in Q1 2025. 147 funds tracked by Wall St. Rank hold OSG as of Q2 2026.

  • Brevan Howard Capital Management reported no remaining Octave Specialty Group position as of Q2 2026 after selling out during the quarter.
  • Brevan Howard Capital Management sold 18,197 Octave Specialty Group shares in Q2 2026, an estimated $84.6K.
  • Brevan Howard Capital Management first reported a position in Octave Specialty Group in Q1 2025 and held it in 5 quarters.
  • Brevan Howard Capital Management's Octave Specialty Group position peaked at $650K in Q1 2025.
  • 147 funds tracked by Wall St. Rank held Octave Specialty Group as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.